| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3405472 | Journal des Anti-infectieux | 2012 | 6 Pages |
Abstract
Histoplasmosis is still unrecognized and its diagnosis is late in metropolitan France. Prognosis remains poor in spite of the availability of active antifungal agents (liposomal amphotericin and itraconazole) and of antiretroviral therapy.
Related Topics
Health Sciences
Medicine and Dentistry
Infectious Diseases
Authors
V. Peigne,